Search Results

A different approach of optimal control on an HIV immunology model.

• Authors : Roshanfekr, Masoud; Farahi, Mohammad Hadi; Rahbarian, Raheleh

Subjects: OPTIMAL control theory; HIV infections; THERAPEUTICS

• Source: Ain Shams Engineering Journal; Mar2014, Vol. 5 Issue 1, p213-219, 7p

Record details

Stochastic frontier production model with undesirable outputs: An application to an HIV immunology model.

• Authors : Fuping Bian^1,2 ; Min Dai^1,2

Subjects: *AIDS; *IMMUNOLOGY; *STOCHASTIC analysis

• Source: Progress in Natural Science. Oct2005, Vol. 15 Issue 10, p943-950. 8p.

Record details

Corrigendum to “Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV”: [Immunology Letters 82/3 (2002) 197–204]

• Authors : Vecino, William H.¹; Morin, Paul M.¹; Agha, Rabia²

• Source: Immunology Letters. Feb2004, Vol. 91 Issue 2/3, p256. 1p.

Record details

Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.

• Authors : Brumme, Zabrina L; Chopera, Denis R; Brockman, Mark A

Subjects: HIV infections; HOST-virus relationships; VIRAL vaccines

• Source: Current Opinion in Virology; Oct2012, Vol. 2 Issue 5, p599-605, 7p

Record details

A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers.

• Authors : Lajoie, J; Juno, J; Burgener, A

• Source: Mucosal Immunology (1933-0219); May2012, Vol. 5 Issue 3, p277-287, 11p

Record details

The gp41 epitope, QARVLAVERY, is highly conserved and a potent inducer of IgA that neutralizes HIV-1 and inhibits viral transcytosis.

• Authors : Jain, S.; Rosenthal, K. L.

• Source: Mucosal Immunology (1933-0219); Sep2011, Vol. 4 Issue 5, p539-553, 15p

Record details

Probabilities of therapeutic extinction of HIV

• Authors : Srinivasa Rao, Arni S.R.¹

Subjects: *HIV infections; *STOCHASTIC processes; *AIDS

• Source: Applied Mathematics Letters. Jan2006, Vol. 19 Issue 1, p80-86. 7p.

Record details

Interactions between malaria and human immunodeficiency virus anno 2014.

• Authors : Van geertruyden, J.-P.¹

Subjects: *MALARIA; *HIV; *PLASMODIUM

• Source: Clinical Microbiology & Infection. Apr2014, Vol. 20 Issue 4, p278-285. 8p.

Record details

Chlamydia pneumoniaein HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR.

• Authors : Woolley, I. J.¹ ; Larsen, M.²; Jones, S.³

Subjects: *INTERFERONS; *ANTIVIRAL agents; *CHLAMYDOPHILA pneumoniae

• Source: Clinical Microbiology & Infection. Sep2004, Vol. 10 Issue 9, p820-825. 6p.

Record details

Serology by the numbers: Analytical performances compared.

• Authors : Galli, C.¹ (AUTHOR); Kolyasnikova, N.¹ (AUTHOR); Zueva, E.¹ (AUTHOR)

Subjects: *SEROLOGY

• Source: Clinica Chimica Acta. Jun2019 Supplement 1, Vol. 493, pS547-S548. 2p.

Record details